Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | USA | Ireland | Imports | Value (US$) | 3,202,065,506.00 | 2,162,172,402.00 | 3,867,109,187.00 | 6,338,847,924.00 | 6,456,731,554.00 | 10,805,822,937.00 | 13,456,155,651.00 | 11,466,212,776.00 | 10,538,227,390.00 | 14,467,808,109.00 | 17,091,461,218.00 | 22,663,751,042.00 |
Value Growth, YoY (%) | -31.33 | -32.47 | 78.85 | 63.91 | 1.85 | 67.35 | 24.52 | -14.78 | -8.09 | 37.28 | 18.13 | 32.60 |
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA from Ireland totalled $ 22 billion in 2023. Sales of commodity group 3002 to USA from Ireland increased by 32% compared to 2022: imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 5.57 billion (the value of sales of commodity group 3002 to USA from Ireland was equal to $17 billion in 2022)
Imports of commodity group 3002 amounted to 27% of total merchandise imports to USA from Ireland (in 2023, total imports to USA from Ireland were $ 82 billion). The share of commodity group 3002 in total imports to USA from Ireland went up by 6.68 p.p. compared to 2022 (it was 20% in 2022 and cumulative imports to USA from Ireland were equal to $ 82 billion).
Imports of commodity group 3002 accounted for 62% of total imports of group "" to USA from Ireland in 2023 (in 2023, the value of imports of commodity group to USA from Ireland was $36 billion). The share of purchases of commodity group 3002 in total imports of commodity group to USA from Ireland increased by 10.5 p.p. compared to 2022 (it was 52% in 2022, and imports of commodity group to USA from Ireland accounted for $32 billion).
The share of Ireland in total imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA amounted to 27 percent (22 billion USD) in 2023 of 81 billion USD - the value of total merchandise imports of commodity group 3002 to USA in 2023. The share of Ireland in imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA increased by 1.27 p.p. compared to 2022 (it was 26 percent in 2022, and total imports of commodity group 3002 to USA were equal to 64 billion USD).